Man Group
APLT

Man Group’s Applied Therapeutics APLT Stock Holding History

Man Group’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-154,636
Closed -$1.05M – 2021
2024
Q1 		$1.05M Sell
154,636
-11,914
-7% -$53.5K ﹤0.01% 1528
2023
Q4 		$558K Buy
+166,550
New +$414K ﹤0.01% 1645
2022
Q4 		– Sell
-11,287
Closed -$10K – 1996
2022
Q3 		$10K Buy
+11,287
New +$13.5K ﹤0.01% 1978

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Man Group's APLT Position: Q2 2024 in Review

Man Group sold out of Applied Therapeutics (APLT) in Q2 2024, closing a stake of 154,636 shares — an estimated $1.05M sold.

Man Group first reported a position in APLT in Q3 2022 and held it in 3 quarters. The position peaked at $1.05M in Q1 2024. 94 funds tracked by Wall St. Rank hold APLT as of Q2 2024.

  • Man Group reported no remaining Applied Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Man Group sold 154,636 Applied Therapeutics shares in Q2 2024, an estimated $1.05M.
  • Man Group first reported a position in Applied Therapeutics in Q3 2022 and held it in 3 quarters.
  • Man Group's Applied Therapeutics position peaked at $1.05M in Q1 2024.
  • 94 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2024.

Based on Man Group's 13F filing for Q2 2024, filed 14 Aug 2024.